Recently, it was suggested that inhibition of ACE/Ang II/AT1 axis or activation of ACE/Ang II/AT1 axis is considered as a potential target for treatment of neurological diseases (de Miranda et al., 2022). The gene discussed is AGT; the disease is nervous system disorder.